Get started
Author

Taro Yoneda

Observed name: T Yoneda
Institution: Komatsu (Japan)
ORCID: 0000-0002-7990-4058
Observed ORCID: 0000-0002-7990-4058
OpenAlex ID: A5061638642
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation
2020 · Wakana Takahashi, Taro Yoneda, et al. · International Journal of Infectious Diseases · 49
PDF
Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression
2020 · Yuichi Tambo, Takashi Sone, et al. · Clinical Lung Cancer · 35
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
2019 · Hideharu Kimura, Tomoyuki Araya, et al. · 癌症：英文版 · 31
PDF
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings
2022 · Taro Yoneda, Takashi Sone, et al. · Clinical Lung Cancer · 28
NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
2021 · Hayato Koba, Hideharu Kimura, et al. · Translational Lung Cancer Research · 22
PDF
Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status
2019 · Hideyuki Katsura, Yukio Suga, et al. · Journal of Cancer · 22
PDF
Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation
2016 · Satoshi Watanabe, Kazuo Kasahara, et al. · The Journal of Heart and Lung Transplantation · 15
PDF
Five-year efficacy and safety of pembrolizumab as first-line treatment in patients with non-small cell lung cancer with PD-L1 tumor proportion score ≥50 %: A multicenter observational study
2025 · Yuichi Tambo, Takashi Sone, et al. · Lung Cancer · 14
PDF
Paradoxical reaction to antituberculosis therapy after 6 months of treatment for pulmonary tuberculosis: A case report
2016 · Akihito Okazaki, Satoshi Watanabe, et al. · Journal of Infection and Chemotherapy · 11
Selective gene amplification to detect the T790M mutation in plasma from patients with advanced non-small cell lung cancer (NSCLC) who have developed epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance
2018 · Shingo Nishikawa, Hideharu Kimura, et al. · Journal of Thoracic Disease · 10
PDF
Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
2020 · Hayato Koba, Taro Yoneda, et al. · Clinical Case Reports · 6
PDF
The measurement of cough response to bronchoconstriction induced by methacholine inhalation in healthy subjects: An examination using the Astograph method
2017 · Johsuke Hara, Masaki Fujimura, et al. · Experimental Lung Research · 6
PDF
Large-cell Neuroendocrine Carcinoma of the Lung with Carcinoid Syndrome
2022 · Makoto Yamamoto, Renma Ito, et al. · Internal Medicine · 5
PDF
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
2021 · Hayato Koba, Hideharu Kimura, et al. · Scientific Reports · 5
PDF
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer
2024 · Nanao Terada, Hayato Koba, et al. · Translational Lung Cancer Research · 3
Postoperative Recurrence of Invasive Thymoma with Cold Agglutinin Disease and Autoimmune Hemolytic Anemia
2016 · Taro Yoneda, Hayato Koba, et al. · Internal Medicine · 3
PDF
Case report: Migraine that persisted for over 20 years disappears after treatment for pulmonary arteriovenous fistula
2020 · Kazuyuki Kakeshita, Taro Yoneda, et al. · Clinical Case Reports · 2
PDF
A retrospective analysis of the efficacy of immune checkpoint inhibitors (ICIs) to advanced non-small cell cancer (NSCLC) patients (pts) with central nerve system (CNS) metastasis.
2018 · Takashi Sone, Kazuo Kasahara, et al. · Journal of Clinical Oncology · 2
A Case of Pulmonary Pleomorphic Carcinoma Associated with Humoral Hypercalcemia of Malignancy Successfully Treated with Carboplatin+Paclitaxel+Bevacizumab Combination Therapy
2017 · Naohiko Ogawa, Hideharu Kimura, et al. · Haigan · 2
PDF
A case of gingival cancer with pulmonary metastases that developed complete atrioventricular block and ventricular fibrillation as a result of myocardial metastases
2016 · Taro Yoneda, Kazumasa Kase, et al. · Clinical Case Reports · 2
PDF
A Rapid and Sensitive Method for Detection of the T790M Mutation of EGFR in Plasma DNA
2016 · Hideharu Kimura, Shingo Nishikawa, et al. · Advances in experimental medicine and biology · 2
Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first‐line therapy in two patients with lung cancer harboring EGFR mutation: Case series
2024 · Hayato Koba, Taro Yoneda, et al. · Thoracic Cancer · 1
PDF
Prolonged response to atezolizumab with bevacizumab plus chemotherapy in a patient with lung cancer harboring mutation in EGFR after Afatinib treatment: A case report
2021 · Hayato Koba, Taro Yoneda, et al. · Current Problems in Cancer Case Reports · 1
PDF
Internal Pancreatic Fistula with Pleural Effusion Showing Elevated Levels of Amylase That Emerged 29 Years after Abdominal Surgery
2020 · Taro Yoneda, Hayato Koba, et al. · Internal Medicine · 1
PDF
A Phase II study to evaluate the efficacy of erlotinib in advanced NSCLC patients who have wild-type EGFR and EGFR gene amplification.
2015 · Takashi Sone, Tomoyuki Araya, et al. · Journal of Clinical Oncology · 1
Works count: 46
Citation count: 282
H-index: 10
I10-index: 10
Year
Topic
Type